Oral sleep apnoea device maker Somnomed is angling for a bite of its rivals after a turnaround led by its co-CEOs.

This was the stock's third consecutive day of losses.

Sleep health technology firm Resmed has announced the UK launch of its latest innovative CPAP (continuous positive airway ...

It’s First Fabric Nasal Mask, Redefining Comfort in Sleep Apnoea TherapyResmed’s innovative CPAP mask is designed to make it easier for people to stick with their treatment and improve overall sleep ...

Using different oximeter devices for monitoring stable patients under NIV or CPAP may have an unpredictable effect on results and clinical decisions.

Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh ( ($AU:RMD) ) has shared an announcement. ResMed Inc. announced an increase ...

The S9 Elite™ is a whisper quiet, elegant and comfortable therapy system for the treatment of Obstructive Sleep Apnoea (OSA). The S9 Elite provides Continuous Positive Airway Pressure (CPAP) with Easy ...

Good afternoon, everybody. My name is Lyanne Harrison. I am the Australian health care analyst here for Bank of America, and I cover ResMed. Today, I have the pleasure of introducing Mick Farrell, ...

ResMed Inc. (NYSE:RMD) Q4 2025 Earnings Call Transcript July 31, 2025 ResMed Inc. beats earnings expectations. Reported EPS is $2.55, expectations were $2.49. Operator: Hello, and welcome to the Q4 ...

Resmed Inc (NYSE:RMD) reported better-than-expected earnings for the second quarter on Thursday. The company posted quarterly earnings of $2.55 per share which beat the analyst consensus estimate of ...

SAN DIEGO, July 01, 2025 (GLOBE NEWSWIRE) -- Resmed (NYSE: RMD, ASX: RMD) today announced it plans to release financial and operational results for the fourth quarter of fiscal year 2025 on Thursday, ...

KeyBanc Capital Markets maintained its Overweight rating and $274.00 price target on ResMed (NYSE:RMD) stock following industry observations. The target aligns with broader analyst expectations, with ...